Navigation Links
MDS Reports Third Quarter 2007 Results
Date:9/6/2007

foreign operations, including the stronger performance this quarter of the late-stage business in MDS Pharma Services. This resulted in the use of tax loss carry forwards in these foreign jurisdictions. The tax benefit of these losses had not previously been recognized in our accounts.

Discontinued Operations

The results of our discontinued businesses for the third quarter of 2007 and 2006 were as follows:

Three months Nine months

to July 31 to July 31

-------------------------------------------------------------------------

2007 2006 2007 2006

-------------------------------------------------------------------------

Net revenues $ - $ 82 $ 95 $ 280

Cost of revenues - (49) (57) (180)

Selling, general and

administration - (11) (15) (38)

Depreciation and amortization - (2) - (7)

Restructuring charges - - - (1)

Equity earnings - 1 1 2

-------------------------------------------------------------------------

Operating income - 21 24 56

Gain on sale of discontinued

operation
'/>"/>

SOURCE MDS Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3More Preemies Born Among the Poor 62390 1More Preemies Born Among the Poor 62390 2ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 62385 1ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 62385 2ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 62385 3Rate of Confirmed AIDS in Prison 2 5 Times the Rate in the U S General Population 62380 1Rate of Confirmed AIDS in Prison 2 5 Times the Rate in the U S General Population 62380 2Rate of Confirmed AIDS in Prison 2 5 Times the Rate in the U S General Population 62380 3